E-LIB Suche - Ergebnisse für: Vassilieva, Svetlana G. - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

CRISPR/Cas9-generated mouse model with humanizing single-ba..:

Polikarpova, Anna V. ; Egorova, Tatiana V. ; Lunev, Evgenii A....
Frontiers in Genome Editing. 5 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

2

CRISPR-Cas9 correction in the DMD mouse model is accompanie..:

Egorova, Tatiana V. ; Polikarpova, Anna V. ; Vassilieva, Svetlana G....
Molecular Therapy - Methods & Clinical Development. 30 (2023) - p. 161-180 , 2023

Link: https://doi.org/10.1016/..

3

In-Frame Deletion of Dystrophin Exons 8–50 Results in DMD P..:

Egorova, Tatiana V. ; Galkin, Ivan I. ; Velyaev, Oleg A....
International Journal of Molecular Sciences. 24 (2023) 11 - p. 9117 , 2023

Link: https://doi.org/10.3390/..

4

Therapeutic potential of highly functional codon-optimized ..:

Starikova, Anna V. ; Skopenkova, Victoria V. ; Polikarpova, Anna V....
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

5

In vitro assay for the efficacy assessment of AAV vectors e..:

Danilov, Kirill A. ; Vassilieva, Svetlana G. ; Polikarpova, Anna V....
Experimental Cell Research. 392 (2020) 2 - p. 112033 , 2020

Link: https://doi.org/10.1016/..

6

CRISPR/Cas9-generated mouse model of Duchenne muscular dyst..:

Egorova, Tatiana V. ; Zotova, Evgenia D. ; Reshetov, Denis A....
Disease Models & Mechanisms. 12 (2019) 4 - p. , 2019

Link: https://doi.org/10.1242/..

7

CRISPR/Cas9-generated mouse model with humanizing single-ba..:

Polikarpova, Anna V ; Egorova, Tatiana V ; Lunev, Evgenii A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106585/. , 2023

Link: http://www.ncbi.nlm.nih...

8

CRISPR-Cas9 correction in the DMD mouse model is accompanie..:

Egorova, Tatiana V ; Polikarpova, Anna V ; Vassilieva, Svetlana G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339130/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Therapeutic potential of highly functional codon-optimized ..:

Starikova, Anna V ; Skopenkova, Victoria V ; Polikarpova, Anna V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764061/. , 2022

Link: http://www.ncbi.nlm.nih...

10

CRISPR/Cas9-generated mouse model with humanizing single-ba..:

Anna V. Polikarpova ; Tatiana V. Egorova ; Evgenii A. Lunev...
https://www.frontiersin.org/articles/10.3389/fgeed.2023.1034720/full. , 2023

Link: https://doi.org/10.3389/..

11

In-Frame Deletion of Dystrophin Exons 8–50 Results in DMD P..:

Tatiana V. Egorova ; Ivan I. Galkin ; Oleg A. Velyaev...
Molecular Pathology, Diagnostics, and Therapeutics. , 2023

Link: https://doi.org/10.3390/..

12

CRISPR-Cas9 correction in the DMD mouse model is accompanie..:

Tatiana V. Egorova ; Anna V. Polikarpova ; Svetlana G. Vassilieva...
http://www.sciencedirect.com/science/article/pii/S2329050123000967. , 2023

Link: https://doi.org/10.1016/..

13

In-Frame Deletion of Dystrophin Exons 8–50 Results in DMD P..:

Tatiana V. Egorova ; Ivan I. Galkin ; Oleg A. Velyaev...
https://www.mdpi.com/1422-0067/24/11/9117. , 2023

Link: https://doi.org/10.3390/..

14

DataSheet1_CRISPR/Cas9-generated mouse model with humanizin..:

Anna V. Polikarpova ; Tatiana V. Egorova ; Evgenii A. Lunev...
doi:10.3389/fgeed.2023.1034720.s001. , 2023

Link: https://doi.org/10.3389/..

15

Therapeutic potential of highly functional codon-optimized ..:

Anna V. Starikova ; Victoria V. Skopenkova ; Anna V. Polikarpova...
https://doi.org/10.1038/s41598-022-04892-x. , 2022

Link: https://doi.org/10.1038/..

1-15

Related subjects